Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Compound for treating or preventing hepatitis B virus infection and preparation method and application thereof

A technology of hepatitis B virus and compound, applied in the field of medicine, can solve the problem of inability to reduce the level of HBsAg

Active Publication Date: 2018-09-14
河南春风医药科技有限公司
View PDF8 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, currently commonly used antiviral drugs such as nucleoside (acid) analogues mainly function to inhibit the DNA synthesis of HBV, but cannot reduce the level of HBsAg in the body.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compound for treating or preventing hepatitis B virus infection and preparation method and application thereof
  • Compound for treating or preventing hepatitis B virus infection and preparation method and application thereof
  • Compound for treating or preventing hepatitis B virus infection and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0136] Embodiment 1 compound A (the compound of formula I)

[0137] Synthetic route of compound A

[0138]

[0139] During the preparation of compound A, specific conditions and operations can refer to similar reactions reported in patent documents US2016 / 0122344 A1 and CN105899508A.

Embodiment 2

[0140] Embodiment 2 Compound B (compound of formula III)

[0141] Synthetic route of compound B

[0142]

[0143]During the preparation of Compound B, specific conditions and operations can refer to similar reactions reported in patent documents US2016 / 0122344 A1 and CN105899508A.

Embodiment 3

[0144] Embodiment 3 compound C (the compound of formula IV)

[0145]

[0146] During the preparation of compound C, specific conditions and operations can refer to similar reactions reported in patent documents US2016 / 0122344 A1 and CN105899508A.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a compound taking quinolizine ketone as a mother nucleus and for treating or preventing hepatitis B virus infection. The compound comprises optical isomer, raceme, cis-trans-isomer and any combination thereof or medicinal salt thereof. The invention further discloses a preparation method and application of the compound. The compound can remarkably lower in-vivo HBsAg leveland inhibit duplication of HBV, has good medicinal attribute and is low in toxicity, and pharmacokinetic and pharmacodynamic functions are improved; efficiency of combining with the HBV can be improved greatly, and clearance rate of in-vivo HBV can be further increased.

Description

[0001] The application of the present invention requires the title of "compounds for the treatment or prevention of hepatitis B virus infection and its preparation method and application", the application date is May 22, 2017, and the application number is 201710363808.X invention, as the invention in the present invention Compounds for treating or preventing hepatitis B virus infection, their preparation methods and applications. technical field [0002] The invention relates to the technical field of medicine, in particular to a quinozinone compound used for treating or preventing hepatitis B virus infection and its preparation method and application. Background technique [0003] As a partially double-stranded DNA virus, hepatitis B virus (HBV) needs to go through a step of reverse transcription from RNA intermediate to DNA for its replication. The HBV genome can encode a variety of antigens including surface antigen (HBsAg) and DNA polymerase required in the process of D...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D471/14C07D491/22C07D491/147C07D498/14C07D498/22A61P31/20
CPCA61P31/20C07D471/14C07D491/147C07D491/22C07D498/14C07D498/22
Inventor 李定芳李竞郭应臣
Owner 河南春风医药科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com